CN108201624A - The preparation and application of isoflavones-chitosan nano compound - Google Patents
The preparation and application of isoflavones-chitosan nano compound Download PDFInfo
- Publication number
- CN108201624A CN108201624A CN201810260375.XA CN201810260375A CN108201624A CN 108201624 A CN108201624 A CN 108201624A CN 201810260375 A CN201810260375 A CN 201810260375A CN 108201624 A CN108201624 A CN 108201624A
- Authority
- CN
- China
- Prior art keywords
- parts
- isoflavones
- chitosan
- preparation
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001661 Chitosan Polymers 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 150000001875 compounds Chemical class 0.000 title claims description 9
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 74
- 244000068988 Glycine max Species 0.000 claims abstract description 73
- 239000000203 mixture Substances 0.000 claims abstract description 46
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 42
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 42
- 230000005855 radiation Effects 0.000 claims abstract description 35
- 150000002515 isoflavone derivatives Chemical class 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims abstract description 21
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000021283 resveratrol Nutrition 0.000 claims abstract description 17
- 229940016667 resveratrol Drugs 0.000 claims abstract description 17
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 13
- 241000005787 Cistanche Species 0.000 claims abstract description 13
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 230000020477 pH reduction Effects 0.000 claims abstract description 9
- 238000001338 self-assembly Methods 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 13
- 241000207925 Leonurus Species 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 6
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 229910017604 nitric acid Inorganic materials 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 240000003152 Rhus chinensis Species 0.000 claims 2
- 235000014220 Rhus chinensis Nutrition 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 2
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 235000013339 cereals Nutrition 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 239000002114 nanocomposite Substances 0.000 abstract description 41
- 230000000694 effects Effects 0.000 abstract description 15
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract description 9
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract description 9
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 abstract description 8
- 239000000284 extract Substances 0.000 abstract description 6
- 240000007890 Leonurus cardiaca Species 0.000 abstract description 2
- 239000007787 solid Substances 0.000 abstract description 2
- 239000003814 drug Substances 0.000 description 22
- 239000000706 filtrate Substances 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229910052770 Uranium Inorganic materials 0.000 description 8
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 8
- 230000003471 anti-radiation Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 210000004698 lymphocyte Anatomy 0.000 description 5
- 239000002105 nanoparticle Substances 0.000 description 5
- 241000143437 Aciculosporium take Species 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000006286 aqueous extract Substances 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229940126589 solid medicine Drugs 0.000 description 3
- 235000003687 soy isoflavones Nutrition 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241001072909 Salvia Species 0.000 description 2
- 235000017276 Salvia Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000219428 Fagaceae Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 201000010001 Silicosis Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003388 anti-hormonal effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- AJNVQOSZGJRYEI-UHFFFAOYSA-N digallium;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Ga+3].[Ga+3] AJNVQOSZGJRYEI-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002539 nanocarrier Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提出了一种大豆异黄酮‑壳聚糖纳米复合物的制备方法和应用,一种大豆异黄酮‑壳聚糖纳米复合物的制备方法,包括以下步骤:(1)大豆异黄酮的酸化;(2)大豆异黄酮与壳聚糖的自组装。取没食子、肉苁蓉益母草、丹参粉碎,混合,煎煮,过滤,浓缩后得到的组合物水提物,加入大豆异黄酮‑壳聚糖纳米复合物和白芦藜醇,喷雾干燥得到固体药粉。本发明所述大豆异黄酮‑壳聚糖纳米复合物和制备的组合物具有明显的防辐射的效果。
The present invention proposes a preparation method and application of soybean isoflavone-chitosan nanocomposite, a kind of preparation method of soybean isoflavone chitosan nanocomposite, comprising the following steps: (1) acidification of soybean isoflavone ; (2) self-assembly of soybean isoflavones and chitosan. The gall, cistanche motherwort and salvia miltiorrhiza are pulverized, mixed, decocted, filtered, and concentrated to obtain a water extract of the composition, added with soybean isoflavone-chitosan nanocomposite and resveratrol, and spray-dried to obtain a solid medicinal powder. The soybean isoflavone-chitosan nanocomposite and the prepared composition of the invention have obvious radiation protection effect.
Description
技术领域technical field
本发明涉及医药技术领域,具体涉及一种纳米复合物的制备及应用。The invention relates to the technical field of medicine, in particular to the preparation and application of a nanocomposite.
背景技术Background technique
我国是铀工业大国,从事铀作业的人员上百万,若加上相关的行业,从业人员更多。对铀作业人员的健康随访研究表明,长期接触铀矿尘与矽肺、肺癌等多种疾病的发生率增高有关。广西区铀矿资源丰富,铀矿作业的职业危害也十分多见。因此,有效的预防铀矿尘损害的医学防护措施具有广阔的应用前景。my country is a big country in the uranium industry, with millions of people engaged in uranium operations. If related industries are added, there will be even more employees. The health follow-up study of uranium workers showed that long-term exposure to uranium dust was associated with an increased incidence of silicosis, lung cancer and other diseases. Guangxi is rich in uranium resources, and occupational hazards in uranium mining operations are also very common. Therefore, effective medical protective measures to prevent uranium dust damage have broad application prospects.
目前的研究表明,大豆异黄酮具有对血管的防护作用、类似女性雌激素作用以及抗激素作用、抑菌活性和预防骨质疏松症等多种生理功能,最近还有研究证实它可能作为一种天然抗氧化剂,而许多天然的抗氧化剂都具有抗辐射、抗肿瘤的功效。大豆异黄酮抗辐射作用表现为能清除体内自由基保护细胞膜脂质及抑制辐射诱导产生的自由基对生物大分子的损伤。因此对大豆异黄酮的抗氧化和抗肿瘤活性进行研究,旨在将其进一步开发为高效、无毒副作用的新型抗氧化剂和抗肿瘤药物提供理论依据。Current studies have shown that soybean isoflavones have a variety of physiological functions such as protective effects on blood vessels, female estrogen-like effects, anti-hormonal effects, antibacterial activity, and prevention of osteoporosis. Natural antioxidants, and many natural antioxidants have anti-radiation and anti-tumor effects. The anti-radiation effect of soybean isoflavones is manifested as the ability to scavenge free radicals in the body to protect cell membrane lipids and inhibit the damage of free radicals induced by radiation to biological macromolecules. Therefore, the research on the antioxidant and antitumor activities of soybean isoflavones aims to provide a theoretical basis for further development of new antioxidants and antitumor drugs with high efficiency and no toxic side effects.
大豆异黄酮的吸收主要在小肠进行,有直接吸收和主动转运两种方式。尚处于实验室研究阶段中的大豆异黄酮缓释剂型,大多都采用了环糊精包埋法,此方法制作工艺复杂,对此剂型大豆异黄酮的大规模工业生产在技术及成本上都有较高的要求。The absorption of soy isoflavones is mainly carried out in the small intestine, and there are two ways: direct absorption and active transport. Most of the sustained-release dosage forms of soybean isoflavones that are still in the laboratory research stage adopt the cyclodextrin embedding method. higher requirements.
通过纳米技术,可以保护某些易氧化易分解的活性物质(如多酌、不饱和脂肪酸、类胡萝卜素),在正确的时间和地点将活性物质释放,实现位点专一性传递,并能够有效地被细胞吸收。在纳米材料的选择上,壳聚糖是甲壳素的脱乙酰化产物,壳聚糖的分子量通常在千几万道尔顿左右,分子结构中的氨基活性集团的存在易解离成带正电荷的阳离子(-NH3+)可以与酸化的大豆异黄酮中大量解离成的带负电的阴离子(-O-和-COO-)相互吸引,自组装成稳定的纳米复合物,在壳聚糖的链接和装载下,实现大豆异黄酮的保护和缓释放。控释聚合纳米粒的出现代表了纳米载体的研制在医药领域迈上了一个新台阶。Through nanotechnology, some active substances that are easy to oxidize and decompose (such as polyhydric acid, unsaturated fatty acids, carotenoids) can be protected, and the active substances can be released at the correct time and place to achieve site-specific delivery, and can Effectively absorbed by cells. In the selection of nanomaterials, chitosan is the deacetylation product of chitin. The molecular weight of chitosan is usually around tens of thousands of daltons. The presence of amino active groups in the molecular structure is easy to dissociate into positively charged The cations (-NH 3+ ) of acidified soy isoflavones can attract each other with the negatively charged anions (-O - and -COO - ) dissociated in a large number in acidified soybean isoflavones, and self-assemble into stable nanocomposites. In chitosan Under the link and loading, the protection and slow release of soy isoflavones are realized. The emergence of controlled-release polymeric nanoparticles represents a new step in the development of nanocarriers in the field of medicine.
没食子为壳斗科植物没食子树幼枝上的十燥虫腰,由没食子蜂科昆虫没食子蜂幼虫寄生面形成,维医称之为”Meha”。没食子具固涩收敛、益血生生精、止血消炎等功效,临床主要用于大肠虚滑、不止、习惯性肠炎、疔疮出血等症的治疗”。没食子在我国用药历史悠久,《唐本草》、《海药本草》、《开宝本草》等中均有记载,以维吾尔医中应用最为普,是维吾尔族医特色传统药材。日前对没食子的研究发现,其对于抗辐射也具有很好的效果。Gallaceae are the dry insect waists on the twigs of the Fagaceae plant Gallia, formed by the parasitic surface of the Gallaceae larvae, which are called "Meha" by Uighur medicine. Gallatum has the functions of solidifying astringent and astringent, benefiting blood and producing essence, hemostasis and anti-inflammation, etc. It is mainly used clinically for the treatment of large intestine slippery, nonstop, habitual enteritis, hemorrhage and other diseases." Gallatum has a long history of medicine in my country, "Tang Materia Medica" , "Haiyao Materia Medica", "Kaibao Materia Medica", etc., are recorded in Uyghur medicine. It is the most popular and traditional medicinal material in Uyghur medicine. A recent study on gallatum found that it also has a good effect on anti-radiation Effect.
发明内容Contents of the invention
为了解决上述的技术问题,本发明提供一种大豆异黄酮-壳聚糖纳米复合物的制备方法,并提供一种该纳米复合物用于防辐射的应用,该纳米复合物与其他中药组合物水提物一起使用,经试验证明,本发明组合物具有明显的抗辐射作用。In order to solve the above-mentioned technical problems, the present invention provides a kind of preparation method of soybean isoflavone-chitosan nanocomposite, and provides a kind of application of this nanocomposite for radiation protection, this nanocomposite and other traditional Chinese medicine composition The water extract is used together, and the test proves that the composition of the present invention has obvious anti-radiation effect.
本发明提供一种大豆异黄酮-壳聚糖纳米复合物的制备方法,包括以下步骤:The invention provides a kind of preparation method of soybean isoflavone-chitosan nanocomposite, comprising the following steps:
(1)大豆异黄酮的酸化:将提取纯化的大豆异黄酮粉末溶于二甲亚砜,加入硝酸,回流8-12h,冷却停止反应,得到酸化的大豆异黄酮;(1) Acidification of soybean isoflavones: dissolve the extracted and purified soybean isoflavones powder in dimethyl sulfoxide, add nitric acid, reflux for 8-12 hours, cool to stop the reaction, and obtain acidified soybean isoflavones;
(2)大豆异黄酮与壳聚糖的自组装:向步骤(1)制备的酸化的大豆异黄酮溶液中加入壳聚糖水溶液,回流12-24h,冷却停止反应,将反应液离心,除去上清液,去离子水反复洗涤纳米颗粒,即得大豆异黄酮-壳聚糖纳米复合物。(2) Self-assembly of soybean isoflavones and chitosan: add chitosan aqueous solution to the acidified soybean isoflavone solution prepared in step (1), reflux for 12-24 hours, cool to stop the reaction, centrifuge the reaction solution, remove the upper clear liquid and deionized water to wash the nanoparticles repeatedly to obtain the soybean isoflavone-chitosan nanocomposite.
作为本发明进一步的改进,大豆异黄酮的酸化反应的回流时间为10h。As a further improvement of the present invention, the reflux time of the acidification reaction of soybean isoflavones is 10 hours.
作为本发明进一步的改进,大豆异黄酮与壳聚糖的自组装反应的回流时间为18h。As a further improvement of the present invention, the reflux time of the self-assembly reaction of soybean isoflavones and chitosan is 18 hours.
作为本发明进一步的改进,离心转速为5000rpm,时间为20min。As a further improvement of the present invention, the centrifugation speed is 5000 rpm and the time is 20 min.
作为本发明进一步的改进,每1g大豆异黄酮用5mL二甲亚砜溶解。As a further improvement of the present invention, every 1 g of soybean isoflavones is dissolved with 5 mL of dimethyl sulfoxide.
作为本发明进一步的改进,壳聚糖水溶液按重量比1:10配制。As a further improvement of the present invention, the chitosan aqueous solution is prepared in a weight ratio of 1:10.
本发明进一步保护一种将上述方法制备的大豆异黄酮-壳聚糖纳米复合物用于防辐射的应用。The present invention further protects the application of the soybean isoflavone-chitosan nanocomposite prepared by the above method for radiation protection.
本发明进一步保护一种一种防辐射组合物,组合物由以下重量份的原料制备而成:大豆异黄酮-壳聚糖纳米复合物15-20份、白藜芦醇15-20份、没食子10-15份、肉苁蓉5-10份、益母草5-7份、丹参2-5份。The present invention further protects a radiation protection composition, which is prepared from the following raw materials in parts by weight: 15-20 parts of soybean isoflavone-chitosan nanocomposite, 15-20 parts of resveratrol, gall 10-15 parts, 5-10 parts of Cistanche, 5-7 parts of Motherwort, 2-5 parts of Salvia.
作为本发明进一步的改进,组合物由以下重量份的原料制备而成:大豆异黄酮-壳聚糖纳米复合物17份、白藜芦醇17份、没食子15份、肉苁蓉8份、益母草6份、丹参3份。As a further improvement of the present invention, the composition is prepared from the following raw materials in parts by weight: 17 parts of soybean isoflavone-chitosan nanocomposite, 17 parts of resveratrol, 15 parts of gall, 8 parts of cistanche, 6 parts of motherwort , Salvia 3 parts.
本发明具有如下有益效果:The present invention has following beneficial effect:
1、本发明引进了纳米壳聚糖链接和装载技术,制备出大豆异黄酮-壳聚糖纳米复合物制剂;1. The present invention introduces nano-chitosan linking and loading technology, and prepares soybean isoflavone-chitosan nanocomposite preparation;
2、本发明重点解决大豆异黄酮-壳聚糖复合物的制备和与中药、维药的配伍,通过实验证明大豆异黄酮-壳聚糖复合物预防铀矿尘辐射对细胞和实验动物损伤的抗辐射有明显作用;2. The present invention focuses on the preparation of the soybean isoflavone-chitosan compound and the compatibility with traditional Chinese medicine and Uyghur medicine. It is proved by experiments that the soybean isoflavone-chitosan compound prevents the damage of uranium mine dust radiation to cells and experimental animals. Anti-radiation has obvious effect;
3、本发明将大豆异黄酮-壳聚糖复合物应用到抗辐射药品的制备中,对现代医学抗辐射有一定的促进作用。3. The present invention applies the soybean isoflavone-chitosan compound to the preparation of anti-radiation medicines, which can promote the anti-radiation of modern medicine to a certain extent.
附图说明Description of drawings
图1是大豆异黄酮-壳聚糖纳米复合物的制备工艺流程图。Fig. 1 is the preparation process flowchart of soybean isoflavone-chitosan nanocomposite.
具体实施方式Detailed ways
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整的描述,显然,所述的实施例只是本发明的部分具有代表性的实施例,而不是全部实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的其他所有实施例都属于本发明的保护范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only some representative embodiments of the present invention, rather than all embodiments. All other embodiments obtained by persons of ordinary skill without making creative efforts belong to the protection scope of the present invention.
实施例1大豆异黄酮-壳聚糖纳米复合物的制备The preparation of embodiment 1 soybean isoflavones-chitosan nanocomposite
按以下步骤进行:Follow these steps:
(1)大豆异黄酮的酸化:将20g提取纯化的大豆异黄酮粉末溶于50mL二甲亚砜,加入硝酸,回流8h,冷却停止反应,得到酸化的大豆异黄酮;(1) Acidification of soybean isoflavones: dissolve 20 g of extracted and purified soybean isoflavones powder in 50 mL of dimethyl sulfoxide, add nitric acid, reflux for 8 hours, cool to stop the reaction, and obtain acidified soybean isoflavones;
(2)大豆异黄酮与壳聚糖的自组装:向步骤(1)制备的酸化的大豆异黄酮溶液中加入0.1g/mL壳聚糖水溶液,回流12h,冷却停止反应,将反应液3000rpm离心10min,除去上清液,去离子水反复洗涤纳米颗粒,即得大豆异黄酮-壳聚糖纳米复合物,得率为67%。(2) Self-assembly of soybean isoflavones and chitosan: add 0.1g/mL chitosan aqueous solution to the acidified soybean isoflavone solution prepared in step (1), reflux for 12h, cool to stop the reaction, and centrifuge the reaction solution at 3000rpm After 10 minutes, the supernatant was removed, and the nanoparticles were repeatedly washed with deionized water to obtain a soybean isoflavone-chitosan nanocomposite with a yield of 67%.
实施例2大豆异黄酮-壳聚糖纳米复合物的制备The preparation of embodiment 2 soybean isoflavones-chitosan nanocomposite
按以下步骤进行:Follow these steps:
(1)大豆异黄酮的酸化:将20g提取纯化的大豆异黄酮粉末溶于100mL二甲亚砜,加入硝酸,回流10h,冷却停止反应,得到酸化的大豆异黄酮;(1) Acidification of soybean isoflavones: dissolve 20 g of extracted and purified soybean isoflavones powder in 100 mL of dimethyl sulfoxide, add nitric acid, reflux for 10 h, cool to stop the reaction, and obtain acidified soybean isoflavones;
(2)大豆异黄酮与壳聚糖的自组装:向步骤(1)制备的酸化的大豆异黄酮溶液中加入0.2g/mL壳聚糖水溶液,回流18h,冷却停止反应,将反应液5000rpm离心20min,除去上清液,去离子水反复洗涤纳米颗粒,即得大豆异黄酮-壳聚糖纳米复合物,得率为92%。(2) Self-assembly of soybean isoflavones and chitosan: add 0.2g/mL chitosan aqueous solution to the acidified soybean isoflavone solution prepared in step (1), reflux for 18h, cool to stop the reaction, and centrifuge the reaction solution at 5000rpm After 20 minutes, the supernatant was removed, and the nanoparticles were repeatedly washed with deionized water to obtain a soybean isoflavone-chitosan nanocomposite with a yield of 92%.
实施例3大豆异黄酮-壳聚糖纳米复合物的制备The preparation of embodiment 3 soybean isoflavones-chitosan nanocomposite
按以下步骤进行:Follow these steps:
(1)大豆异黄酮的酸化:将20g提取纯化的大豆异黄酮粉末溶于150mL二甲亚砜,加入硝酸,回流12h,冷却停止反应,得到酸化的大豆异黄酮;(1) Acidification of soybean isoflavones: dissolve 20 g of extracted and purified soybean isoflavones powder in 150 mL of dimethyl sulfoxide, add nitric acid, reflux for 12 hours, cool to stop the reaction, and obtain acidified soybean isoflavones;
(2)大豆异黄酮与壳聚糖的自组装:向步骤(1)制备的酸化的大豆异黄酮溶液中加入0.5g/mL壳聚糖水溶液,回流24h,冷却停止反应,将反应液8000rpm离心30min,除去上清液,去离子水反复洗涤纳米颗粒,即得大豆异黄酮-壳聚糖纳米复合物,得率为79%。(2) Self-assembly of soybean isoflavones and chitosan: add 0.5g/mL chitosan aqueous solution to the acidified soybean isoflavone solution prepared in step (1), reflux for 24h, cool to stop the reaction, and centrifuge the reaction solution at 8000rpm After 30 minutes, the supernatant was removed, and the nanoparticles were repeatedly washed with deionized water to obtain a soybean isoflavone-chitosan nanocomposite with a yield of 79%.
实施例4防辐射组合物的制备The preparation of embodiment 4 radiation protection composition
原料组成:大豆异黄酮-壳聚糖纳米复合物20份、白藜芦醇20份、没食子15份、肉苁蓉10份、益母草7份、丹参5份。Composition of raw materials: 20 parts of soybean isoflavone-chitosan nanocomposite, 20 parts of resveratrol, 15 parts of gall, 10 parts of cistanche, 7 parts of motherwort, 5 parts of salvia miltiorrhiza.
制备步骤:Preparation steps:
a、取没食子、肉苁蓉、益母草、丹参粉碎后混合,加入10倍体积水,浸泡40min,煎煮2h,减压过滤,滤液备用;a. Take gallaceae, cistanche, motherwort, and salvia miltiorrhiza, mix them, add 10 times the volume of water, soak for 40 minutes, decoct for 2 hours, filter under reduced pressure, and set aside the filtrate;
b、在步骤a所得药渣中加入5倍体积水,煎煮1.5h,减压过滤,滤液备用;b. Add 5 times the volume of water to the dregs obtained in step a, decoct for 1.5 hours, filter under reduced pressure, and the filtrate is set aside;
c、将步骤a和步骤b所得滤液合并,过400目筛,浓缩滤液至相对密度1.0-1.3,即得中药组合物水提物。c. Combine the filtrates obtained in step a and step b, pass through a 400-mesh sieve, and concentrate the filtrate to a relative density of 1.0-1.3 to obtain the aqueous extract of the Chinese medicine composition.
d、将大豆异黄酮-壳聚糖纳米复合物和白芦藜醇用乙醇溶液溶解后加入到中药组合物水提物中,并喷雾干燥,得到固体药粉。d. Dissolving the soybean isoflavone-chitosan nanocomposite and resveratrol with ethanol solution, adding it to the water extract of the traditional Chinese medicine composition, and spraying and drying to obtain a solid medicine powder.
实施例5防辐射组合物的制备The preparation of embodiment 5 radiation protection composition
原料组成:大豆异黄酮-壳聚糖纳米复合物17份、白藜芦醇17份、没食子15份、肉苁蓉8份、益母草6份、丹参3份。Composition of raw materials: 17 parts of soybean isoflavone-chitosan nanocomposite, 17 parts of resveratrol, 15 parts of gall, 8 parts of cistanche, 6 parts of motherwort, 3 parts of salvia miltiorrhiza.
a、取没食子、肉苁蓉、益母草、丹参粉碎后混合,加入10倍体积水,浸泡40min,煎煮2h,减压过滤,滤液备用;a. Take gallaceae, cistanche, motherwort, and salvia miltiorrhiza, mix them, add 10 times the volume of water, soak for 40 minutes, decoct for 2 hours, filter under reduced pressure, and set aside the filtrate;
b、在步骤a所得药渣中加入5倍体积水,煎煮1.5h,减压过滤,滤液备用;b. Add 5 times the volume of water to the dregs obtained in step a, decoct for 1.5 hours, filter under reduced pressure, and the filtrate is set aside;
c、将步骤a和步骤b所得滤液合并,过400目筛,浓缩滤液至相对密度1.0-1.3,即得中药组合物水提物。c. Combine the filtrates obtained in step a and step b, pass through a 400-mesh sieve, and concentrate the filtrate to a relative density of 1.0-1.3 to obtain the aqueous extract of the Chinese medicine composition.
d、将大豆异黄酮-壳聚糖纳米复合物和白芦藜醇用乙醇溶液溶解后加入到中药组合物水提物中,并喷雾干燥,得到固体药粉。d. Dissolving the soybean isoflavone-chitosan nanocomposite and resveratrol with ethanol solution, adding it to the water extract of the traditional Chinese medicine composition, and spraying and drying to obtain a solid medicine powder.
实施例6防辐射组合物的制备The preparation of embodiment 6 radiation protection composition
原料组成:大豆异黄酮-壳聚糖纳米复合物15份、白藜芦醇15份、没食子10份、肉苁蓉5份、益母草5份、丹参2份。Composition of raw materials: 15 parts of soybean isoflavone-chitosan nanocomposite, 15 parts of resveratrol, 10 parts of gall, 5 parts of cistanche, 5 parts of motherwort, 2 parts of salvia miltiorrhiza.
a、取没食子、肉苁蓉、益母草、丹参粉碎后混合,加入10倍体积水,浸泡40min,煎煮2h,减压过滤,滤液备用;a. Take gallaceae, cistanche, motherwort, and salvia miltiorrhiza, mix them, add 10 times the volume of water, soak for 40 minutes, decoct for 2 hours, filter under reduced pressure, and set aside the filtrate;
b、在步骤a所得药渣中加入5倍体积水,煎煮1.5h,减压过滤,滤液备用;b. Add 5 times the volume of water to the dregs obtained in step a, decoct for 1.5 hours, filter under reduced pressure, and the filtrate is set aside;
c、将步骤a和步骤b所得滤液合并,过400目筛,浓缩滤液至相对密度1.0-1.3,即得中药组合物水提物。c. Combine the filtrates obtained in step a and step b, pass through a 400-mesh sieve, and concentrate the filtrate to a relative density of 1.0-1.3 to obtain the aqueous extract of the Chinese medicine composition.
d、将大豆异黄酮-壳聚糖纳米复合物和白芦藜醇用乙醇溶液溶解后加入到中药组合物水提物中,并喷雾干燥,得到固体药粉。d. Dissolving the soybean isoflavone-chitosan nanocomposite and resveratrol with ethanol solution, adding it to the water extract of the traditional Chinese medicine composition, and spraying and drying to obtain a solid medicine powder.
实施例7不含大豆异黄酮-壳聚糖纳米复合物的防辐射组合物的制备Embodiment 7 does not contain the preparation of the radiation protection composition of soybean isoflavone-chitosan nanocomposite
原料组成:白藜芦醇17份、没食子15份、肉苁蓉8份、益母草6份、丹参3份。Composition of raw materials: 17 parts of resveratrol, 15 parts of gall, 8 parts of cistanche, 6 parts of motherwort, 3 parts of salvia miltiorrhiza.
a、取没食子、肉苁蓉、益母草、丹参粉碎后混合,加入10倍体积水,浸泡40min,煎煮2h,减压过滤,滤液备用;a. Take gallaceae, cistanche, motherwort, and salvia miltiorrhiza, mix them, add 10 times the volume of water, soak for 40 minutes, decoct for 2 hours, filter under reduced pressure, and set aside the filtrate;
b、在步骤a所得药渣中加入5倍体积水,煎煮1.5h,减压过滤,滤液备用;b. Add 5 times the volume of water to the dregs obtained in step a, decoct for 1.5 hours, filter under reduced pressure, and the filtrate is set aside;
c、将步骤a和步骤b所得滤液合并,过400目筛,浓缩滤液至相对密度1.0-1.3,即得中药组合物水提物。c. Combine the filtrates obtained in step a and step b, pass through a 400-mesh sieve, and concentrate the filtrate to a relative density of 1.0-1.3 to obtain the aqueous extract of the Chinese medicine composition.
d、将白芦藜醇用乙醇溶液溶解后加入到中药组合物水提物中,并喷雾干燥,得到固体药粉。d. Dissolving resveratrol with ethanol solution, adding it to the water extract of the traditional Chinese medicine composition, and spray drying to obtain solid medicinal powder.
试验例1小鼠试验Test Example 1 Mouse Test
1、实验组别。准备140只成年小白鼠,分为7组,每组20只,分别为大豆异黄酮粉组(1组)、实施例2制备的大豆异黄酮-壳聚糖纳米复合物组(2组)、实施例7制备的不含大豆异黄酮-壳聚糖纳米复合物的防辐射组合物(3组)、实施例5制备的防辐射组合物(4组)、白芦藜醇组、对照组和空白组。1. Experimental group. Prepare 140 adult mice, be divided into 7 groups, every group of 20, be respectively the soybean isoflavone powder group (1 group), the soybean isoflavone-chitosan nanocomposite group (2 groups) prepared in embodiment 2, The radiation protection composition (3 groups) that does not contain soybean isoflavone-chitosan nanocomposite that embodiment 7 prepares, the radiation protection composition (4 groups) that embodiment 5 prepares, resveratrol group, control group and blank group.
2、实验方法。1~5组每天清晨灌胃给药:1组给药大豆异黄酮粉100mg/kg,2组给药实施例2制备的大豆异黄酮-壳聚糖纳米复合物100mg/kg,3组给药实施例7制备的不含大豆异黄酮-壳聚糖纳米复合物的防辐射组合物100mg/kg,4组给药实施例5制备的防辐射组合物100mg/kg,5组给药白芦藜醇100mg/kg,对照组和空白组灌胃蒸馏水100mg/kg。各组药粉均溶于水后进行灌胃。喂养14d后,用60Co放射线照射1~5组和对照组大鼠,照射距离75cm,照射视野20cm×20cm,照射时间8min。于照射的第1、7、15、22、30天取血,用全自动生化分析仪测定血液生理指标。2. Experimental method. Groups 1 to 5 were intragastrically administered every morning: group 1 administered soybean isoflavone powder 100 mg/kg, group 2 administered soybean isoflavone-chitosan nanocomposite 100 mg/kg prepared in Example 2, group 3 administered The radiation protection composition 100mg/kg that does not contain the soybean isoflavone-chitosan nanocomposite prepared in Example 7, 4 groups of administration The radiation protection composition 100mg/kg prepared in Example 5, 5 groups of administration of resveratrol Alcohol 100mg/kg, control group and blank group gavage distilled water 100mg/kg. The medicinal powders of each group were dissolved in water and administered into the stomach. After feeding for 14 days, the rats in groups 1-5 and the control group were irradiated with 60 Co radiation, the irradiation distance was 75cm, the irradiation field of view was 20cm×20cm, and the irradiation time was 8min. Blood was collected on the 1st, 7th, 15th, 22nd, and 30th days of irradiation, and blood physiological indicators were measured with an automatic biochemical analyzer.
实验结果见表1~表3。The experimental results are shown in Table 1-Table 3.
表1小鼠外周血红细胞计数(×1012/L)Table 1 Peripheral red blood cell count of mice (×10 12 /L)
辐射后小白鼠外周血红细胞水平有所下降,在22d下降到最低点,而后红细胞数量开始缓慢上升,由以上结果可知,1~5组和对照组基本变化规律一致,均为先降低后升高,但是本发明防辐射组合物组(4组)在辐射后外周血红细胞水平明显高于其他组,且较为稳定、恢复速度快,白芦藜醇组(5组)、不含大豆异黄酮-壳聚糖纳米复合物的防辐射组合物(3组)和大豆异黄酮-壳聚糖纳米复合物组(2组)的外周血红细胞水平虽高于对照组,有一定的防辐射作用,但是效果远低于4组,可见,本发明防辐射组合物将白芦藜醇、大豆异黄酮-壳聚糖纳米复合物和其他中药组合物组合后具有明显的协同增效作用。After radiation, the level of red blood cells in the peripheral blood of the mice decreased, and dropped to the lowest point at 22 days, and then the number of red blood cells began to increase slowly. From the above results, it can be seen that the basic change rules of groups 1 to 5 and the control group are consistent, and both decrease first and then increase , but the radiation protection composition group (group 4) of the present invention had significantly higher levels of peripheral red blood cells after radiation than other groups, and it was relatively stable and recovered quickly. The resveratrol group (group 5), without soybean isoflavone- Although the radiation protection composition of chitosan nanocomposite (group 3) and soybean isoflavone-chitosan nanocomposite group (group 2) have a higher level of peripheral blood erythrocytes than the control group, there is a certain radiation protection effect, but The effect is far lower than that of group 4. It can be seen that the combination of resveratrol, soy isoflavone-chitosan nanocomposite and other traditional Chinese medicine compositions in the radiation protection composition of the present invention has obvious synergistic effect.
表2小鼠外周血小板计数(×109/L)Table 2 Mouse peripheral platelet count (×10 9 /L)
接受辐射后小白鼠血小板数量明显降低,到第22d下降到最低点,之后开始缓慢上升。由以上结果可知,1~5组和对照组基本变化规律一致,均为先降低后升高,但是本发明防辐射组合物组(4组)在辐射后血小板数量明显高于其他组,且较为稳定、恢复速度快,白芦藜醇组(5组)、不含大豆异黄酮-壳聚糖纳米复合物的防辐射组合物(3组)和大豆异黄酮-壳聚糖纳米复合物组(2组)的血小板数量虽高于对照组,有一定的防辐射作用,但是效果远低于4组,可见,本发明防辐射组合物将白芦藜醇、大豆异黄酮-壳聚糖纳米复合物和其他中药组合物组合后具有明显的协同增效作用。After receiving radiation, the number of platelets in the mice decreased significantly, dropped to the lowest point on the 22nd day, and then began to rise slowly. From the above results, it can be known that groups 1 to 5 and the control group have basically the same changing rules, both of which decrease first and then increase, but the number of platelets in the radiation protection composition group of the present invention (group 4) is significantly higher than that of other groups after radiation, and is relatively Stable and fast recovery, resveratrol group (5 groups), radiation protection composition without soybean isoflavone-chitosan nanocomposite (3 groups) and soybean isoflavone-chitosan nanocomposite group ( Although the number of platelets in 2 groups) is higher than that of the matched group, there is a certain radiation protection effect, but the effect is far lower than that of 4 groups. It can be seen that the radiation protection composition of the present invention combines resveratrol, soybean isoflavone-chitosan nano It has obvious synergistic effect after being combined with other traditional Chinese medicine compositions.
表3小鼠淋巴细胞计数(×109/L)Table 3 Mouse lymphocyte count (×10 9 /L)
小白鼠外周血淋巴细胞数量可一定程度反映辐射对免疫功能的影响,辐射对淋巴细胞的杀伤作用明显,照射后小白鼠外周血淋巴细胞数量下降,第7d降至最低,随着时间的延长缓慢增加,但至实验结束仍未恢复至正常水平。由以上结果可知,1~5组和对照组基本变化规律一致,但是本发明防辐射组合物组(4组)在辐射后淋巴细胞水平明显优于其他组,白芦藜醇组(5组)、不含大豆异黄酮-壳聚糖纳米复合物的防辐射组合物(3组)和大豆异黄酮-壳聚糖纳米复合物组(2组)的淋巴细胞水平虽高于对照组,有一定的防辐射作用,但是效果远低于4组,可见,本发明防辐射组合物将白芦藜醇、大豆异黄酮-壳聚糖纳米复合物和其他中药组合物组合后具有明显的协同增效作用。The number of lymphocytes in the peripheral blood of mice can reflect the effect of radiation on immune function to a certain extent. The killing effect of radiation on lymphocytes is obvious. increased, but did not return to normal levels by the end of the experiment. From the above results, it can be known that groups 1 to 5 are basically consistent with the control group, but the level of lymphocytes in the radiation protection composition group of the present invention (group 4) is significantly better than other groups after radiation, and the resveratrol group (group 5) , the radiation protection composition (3 groups) without soybean isoflavone-chitosan nanocomposite and the lymphocyte level of soybean isoflavone-chitosan nanocomposite group (2 groups) though higher than the control group, there is a certain Radiation protection effect, but the effect is far lower than 4 groups, it can be seen that the radiation protection composition of the present invention has obvious synergistic effect after combining resveratrol, soybean isoflavone-chitosan nanocomposite and other traditional Chinese medicine compositions effect.
本领域的技术人员在不脱离权利要求书确定的本发明的精神和范围的条件下,还可以对以上内容进行各种各样的修改。因此本发明的范围并不仅限于以上的说明,而是由权利要求书的范围来确定的。Various modifications can be made to the above contents by those skilled in the art without departing from the spirit and scope of the present invention defined by the claims. Therefore, the scope of the present invention is not limited to the above description, but is determined by the scope of the claims.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810260375.XA CN108201624A (en) | 2018-03-27 | 2018-03-27 | The preparation and application of isoflavones-chitosan nano compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810260375.XA CN108201624A (en) | 2018-03-27 | 2018-03-27 | The preparation and application of isoflavones-chitosan nano compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108201624A true CN108201624A (en) | 2018-06-26 |
Family
ID=62606843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810260375.XA Pending CN108201624A (en) | 2018-03-27 | 2018-03-27 | The preparation and application of isoflavones-chitosan nano compound |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108201624A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1695607A (en) * | 2004-05-12 | 2005-11-16 | 中国人民解放军军事医学科学院卫生学环境医学研究所 | New application of isoflavone of soybean |
| CN102000045A (en) * | 2010-10-21 | 2011-04-06 | 中国医学科学院放射医学研究所 | Application of resveratrol in preparing medicament for preventing and treating radiation induced depigmentation skin disease |
| CN103099798A (en) * | 2013-01-29 | 2013-05-15 | 浙江中医药大学 | Preparation method of soybean isoflavone-chitosan slow-release microcapsules |
| WO2013086313A1 (en) * | 2011-12-09 | 2013-06-13 | Mousa Shaker A | Nanoformulation of vitamin d derivatives and/or vitamin d metabolites |
-
2018
- 2018-03-27 CN CN201810260375.XA patent/CN108201624A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1695607A (en) * | 2004-05-12 | 2005-11-16 | 中国人民解放军军事医学科学院卫生学环境医学研究所 | New application of isoflavone of soybean |
| CN102000045A (en) * | 2010-10-21 | 2011-04-06 | 中国医学科学院放射医学研究所 | Application of resveratrol in preparing medicament for preventing and treating radiation induced depigmentation skin disease |
| WO2013086313A1 (en) * | 2011-12-09 | 2013-06-13 | Mousa Shaker A | Nanoformulation of vitamin d derivatives and/or vitamin d metabolites |
| CN103099798A (en) * | 2013-01-29 | 2013-05-15 | 浙江中医药大学 | Preparation method of soybean isoflavone-chitosan slow-release microcapsules |
Non-Patent Citations (2)
| Title |
|---|
| 周湘洁 等: ""番红花培养细胞对辐射小鼠外周血细胞的保护作用"", 《中国药业》 * |
| 谢玄: ""三羟基异黄酮壳聚糖纳米体的制备及其体内吸收、抗氧化研究"", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102151241B (en) | Toothpaste containing natural plant extractive and preparation method thereof | |
| CN103463531B (en) | Use of rhizoma smilacis glabrae extract in preparation of lipid-lowering and fat-reducing medicines and health-care foods | |
| CN102430090A (en) | Traditional Tibetan medicine Ruyizhenbao composite preparation and preparation method thereof | |
| CN1709474A (en) | Cosmetic preparation for skin removal, whitening and wrinkle removal and preparation method thereof | |
| Deshpande et al. | Phytosomes: A novel drug delivery system for phytoconstituents | |
| CN108014150A (en) | Application of the natural drug composition in anti anoxia and radiation-resistant medicine or food is prepared | |
| CN104667195A (en) | Composition for protecting liver, preparation method thereof and traditional Chinese medicine preparation | |
| CN1038585A (en) | Clear away heart-fire liquid and preparation method thereof | |
| CN1554324A (en) | Chinese herbal toothpaste | |
| CN108201624A (en) | The preparation and application of isoflavones-chitosan nano compound | |
| CN105193650B (en) | Preparation method of Ginseng radix and Larix Gmelini extract and its application in cosmetic | |
| CN108434225A (en) | A kind of Chinese medicine composition and its preparation method and application for treating senile skin itch | |
| US7431946B2 (en) | Method for producing extracts of Boehmeria frutescens thunberg or Boehmeria nivea for hepatitis treatment | |
| CN100509796C (en) | Extraction method of Chinese medicine of gold buckwheat raw anthocyanin | |
| CN102614228B (en) | Application of pine needle fat-soluble extract to preparation of tumor treating medicament | |
| CN101849630B (en) | Astragalus health-care food and preparation method thereof | |
| CN106539892B (en) | A kind of cat's claw traditional Chinese medicine composition and preparation method and application thereof | |
| CN1155399C (en) | Application of pilose gerbera herb in preparing antineoplastic medicine | |
| CN105343260A (en) | Pharmaceutical for treating chronic ulcerative colitis and its preparation method | |
| CN106309736B (en) | Anti-fatigue traditional Chinese medicine composition and its preparation method and application | |
| Fakhri et al. | Acute and sub-chronic toxicity evaluation of aqueous extract of Phoenix dactylifera seeds in Wistar rats | |
| Mansoor et al. | Phytochemical and nephroprotective activity of Ginkgo biloba against gentamicin-induced nephrotoxicity in rats | |
| TW201902504A (en) | Use of Nanyangshan Sushui Extract | |
| CN105412391A (en) | Health care food formula having auxiliary antioxidant function and preparation method of health care food formula | |
| JP2022551290A (en) | A preventive or therapeutic composition for neurodegenerative diseases, containing a complex crude drug extract of Pseudophylla spp. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180626 |
|
| RJ01 | Rejection of invention patent application after publication |